0001493152-23-042659.txt : 20231124 0001493152-23-042659.hdr.sgml : 20231124 20231124160005 ACCESSION NUMBER: 0001493152-23-042659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231121 FILED AS OF DATE: 20231124 DATE AS OF CHANGE: 20231124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Csimma Cristina CENTRAL INDEX KEY: 0001501623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33672 FILM NUMBER: 231436699 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CENTER, BLDG 1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PALISADE BIO, INC. CENTRAL INDEX KEY: 0001357459 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 522007292 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7750 EL CAMINO REAL, SUITE 5200 CITY: CARLSBAD STATE: CA ZIP: 92009 BUSINESS PHONE: (858) 704-4900 MAIL ADDRESS: STREET 1: 7750 EL CAMINO REAL, SUITE 5200 CITY: CARLSBAD STATE: CA ZIP: 92009 FORMER COMPANY: FORMER CONFORMED NAME: Seneca Biopharma, Inc. DATE OF NAME CHANGE: 20200127 FORMER COMPANY: FORMER CONFORMED NAME: Neuralstem, Inc. DATE OF NAME CHANGE: 20060324 4 1 ownership.xml X0508 4 2023-11-21 0 0001357459 PALISADE BIO, INC. PALI 0001501623 Csimma Cristina 7750 EL CAMINO REAL, SUITE 2A CARLSBAD, CA 92009 1 0 0 0 0 Restricted Stock Units 2023-11-21 4 A 0 5820 0.00 A Common Stock 5820 5820 D Common Stock Options 0.59 2023-11-21 4 A 0 6880 0.00 A 2033-11-21 Common Stock 6880 6880 D Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee. The grants vest fully on the one (1) year anniversary of the grant date. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. N/A. Each option represents the right to purchase one share of common stock at the exercise price. /s/ Cristina Csimma 2023-11-24